Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 8769 - 8776 of 12085 results

Governor Baker Announces Mid-Year Budget Cuts
January 11, 2016| Alert| Viewpoint

Health Care Enforcement Report: A Look Back at 2015 and a Forecast for 2016
January 11, 2016| Blog| Viewpoint

A New Year’s Resolution: Avoid The Rising Tide of Defamation Claims In The Health Care Arena
January 8, 2016| Blog| Viewpoint

DHS Proposes New Rule for Increased Job Flexibility: Part 1
January 8, 2016| Blog| Viewpoint

Outlook 2016: More FCA Cases, Enforcement against Individuals
January 8, 2016| News

Cadillac Tax Effective Date Postponed (and Three Other 2015 Year End Health and Welfare Benefits Legislation Highlights)
January 7, 2016| Blog| Viewpoint

The Fourth Circuit’s Countdown to 2016 Includes Two FLSA Classification Decisions
January 7, 2016| Blog| Viewpoint

COP21 Accord Set to Make Waves in Energy Industry
January 7, 2016| Blog| Viewpoint
News & Press Releases
Mintz advised the creators of Morbid, one of the top-charting true crime podcasts, in a multi-year agreement to move to SiriusXM from Wondery. The deal gives SiriusXM exclusive advertising rights for the audio and video formats of the podcast.
Mintz Advises CVC DIF in Acquisition of SBA Communications’ Canadian Tower Infrastructure Platform
August 06, 2025
Mintz advised CVC DIF, the dedicated infrastructure investment strategy of global private markets manager CVC, in its agreement to acquire SBA Communications’ Canadian wireless tower business, one of Canada’s leading independent owners and operators of wireless communications towers. The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions.
Mintz advised the underwriters in connection with a $69 million public offering by Larimar Therapeutics, Inc. of 21,562,500 shares of its common stock at a price to the public of $3.20 per share. The gross proceeds to Larimar from the offering were $69 million before deducting underwriting discounts and commissions and other offering expenses.
Events
Podcasts

Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|

Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
